Lv1
40 积分 2023-01-13 加入
An optimized IL-12-Fc expands its therapeutic window, achieving strong activity against mouse tumors at tolerable drug doses
13天前
已完结
A PD-L1xCD3 bispecific nanobody as a novel T-cell engager in treating PD-L1 overexpression melanoma
3个月前
已完结
Analysis of cancer drugs receiving FDA’s Accelerated Approval between 1992 and 2021
4个月前
已完结
Clinical Benefit and Regulatory Outcomes of Cancer Drugs Receiving Accelerated Approval
4个月前
已完结
Analysis of cancer drugs receiving FDA’s Accelerated Approval between 1992 and 2021
4个月前
已关闭
Comprehensive physicochemical and functional analysis of pembrolizumab based on controlled degradation studies: Impact on antigen–antibody binding
4个月前
已完结
Abstract 2712: Development of GB268, a tri-specific antibody targeting PD-1/CTLA-4/VEGF, with enhanced anti-tumor efficacy and reduced toxicity in pre-clinical studies
4个月前
已关闭
Dual CTLA‐4 and PD‐1 checkpoint blockade using CS1002 and CS1003 (nofazinlimab) in patients with advanced solid tumors: A first‐in‐human, dose‐escalation, and dose‐expansion study
4个月前
已完结
Fine Epitope Mapping of the CD19 Extracellular Domain Promotes Design
5个月前
已完结
Singling out the immune-suppressive TME in prostate cancer
6个月前
已关闭
Reassessing the Effect of Colour on Attitude and Behavioural Intentions in Promotional Activities: The Moderating Role of Mood and Involvement
皖公网安备34019202002308
